TrivarX (ASX:TRI) ROE % Adjusted to Book Value : -2.67% (As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is TrivarX ROE % Adjusted to Book Value?

TrivarX's ROE % for the quarter that ended in Dec. 2024 was -1.71%. TrivarX's PB Ratio for the quarter that ended in Dec. 2024 was 0.64. TrivarX's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -2.67%.

TrivarX ROE % Adjusted to Book Value Historical Data

The historical data trend for TrivarX's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX ROE % Adjusted to Book Value Chart

TrivarX Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-70.21

-13.31

-186.05

-65.35

-14.70

TrivarX Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-12.97	-110.72	-24.63	-3.19	-2.67

Competitive Comparison of TrivarX's ROE % Adjusted to Book Value

For the Health Information Services subindustry, TrivarX's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TrivarX's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TrivarX's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where TrivarX's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

TrivarX ROE % Adjusted to Book Value Calculation

TrivarX's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-15.29%	/	1.04
	=	-14.70%

TrivarX's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-1.71%	/	0.64
	=	-2.67%

TrivarX ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of TrivarX's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

TrivarX Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (ASX:TRI) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

647 Beaufort Street, Mount Lawley, WA, AUS, 6050

Website

https://www.trivarx.com

TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.